BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20547552)

  • 1. Contaminants in heparins: are all facts known?
    Fareed J; Hoppensteadt DA; Ramacciotti E; Hull RD
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):242-3. PubMed ID: 20547552
    [No Abstract]   [Full Text] [Related]  

  • 2. Contaminated heparin-affected patient plasmas are associated with activated contact systems.
    Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Beck AM; Shih FF; Lijuan Zhang
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):261-5. PubMed ID: 20547554
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT.
    Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Shih FF; Porche-Sorbet R; Eby C; Lijuan Zhang
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):251-60. PubMed ID: 20460351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contaminants in heparin.
    Hull R; Walenga J
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):125. PubMed ID: 21406418
    [No Abstract]   [Full Text] [Related]  

  • 5. Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications.
    Ramacciotti E; Clark M; Sadeghi N; Hoppensteadt D; Thethi I; Gomes M; Fareed J
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):126-35. PubMed ID: 21288929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oversulfated heparin by-products induce thrombin generation in human plasmas through contact system activation.
    Yi Qian ; Jing Pan ; Xiaodong Zhou ; Hourcade DE; Liszewski MK; Atkinson JP; Hong Lu ; Lijuan Zhang
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):244-50. PubMed ID: 20547553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Artificial polysaccharide in contaminated heparin. Acute hypersensitivity reactions explained--but how could it happen?].
    Lindahl U
    Lakartidningen; 2008 Sep 24-30; 105(39):2660-1. PubMed ID: 18846871
    [No Abstract]   [Full Text] [Related]  

  • 8. Contaminants in heparins continue to be unfolded.
    Fareed J; Ahluwalia M; Wahi R; Ramaccioti E; Hoppensteadt D; Bick RL
    Int Angiol; 2008 Dec; 27(6):457-61. PubMed ID: 19078906
    [No Abstract]   [Full Text] [Related]  

  • 9. The tainted heparin story: an update.
    Guerrini M; Shriver Z; Bisio A; Naggi A; Casu B; Sasisekharan R; Torri G
    Thromb Haemost; 2009 Nov; 102(5):907-11. PubMed ID: 19888527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and generic anticoagulants and biosimilars: safety considerations.
    Kalodiki E; Fareed J
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):136-9. PubMed ID: 21159711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contaminated heparin.
    Kakkar AK; Bonnefoi M
    N Engl J Med; 2008 Sep; 359(12):1292-3; author reply 1293. PubMed ID: 18810795
    [No Abstract]   [Full Text] [Related]  

  • 12. Contaminated heparin.
    Greinacher A; Warkentin TE
    N Engl J Med; 2008 Sep; 359(12):1291-2; author reply 1293. PubMed ID: 18799565
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anaphylactoid reactions associated with contaminated heparin from China].
    Montpas N; Désormeaux A; Keire D; Adam A
    Ann Pharm Fr; 2011 Sep; 69(5):258-64. PubMed ID: 21924126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From crisis to opportunity: a perspective on the heparin crisis.
    Sasisekharan R; Shriver Z
    Thromb Haemost; 2009 Nov; 102(5):854-8. PubMed ID: 19888519
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contaminated heparins].
    Monneret C
    Ann Pharm Fr; 2008 Aug; 66(4):212-5. PubMed ID: 18847567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contaminated heparin preparations, severe adverse events and the contact system.
    Ramacciotti E; Wahi R; Messmore HL
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):489-91. PubMed ID: 18815138
    [No Abstract]   [Full Text] [Related]  

  • 17. [How safe is our treatment with heparins? (interview by Maria Weiss)].
    Lindhoff-Last E
    MMW Fortschr Med; 2008 May; 150(22):7. PubMed ID: 18700259
    [No Abstract]   [Full Text] [Related]  

  • 18. Prothrombin time for detection of contaminated heparins.
    Alban S; Lühn S
    N Engl J Med; 2008 Dec; 359(25):2732-4. PubMed ID: 19052118
    [No Abstract]   [Full Text] [Related]  

  • 19. Contaminated heparin associated with adverse clinical events and activation of the contact system.
    Kishimoto TK; Viswanathan K; Ganguly T; Elankumaran S; Smith S; Pelzer K; Lansing JC; Sriranganathan N; Zhao G; Galcheva-Gargova Z; Al-Hakim A; Bailey GS; Fraser B; Roy S; Rogers-Cotrone T; Buhse L; Whary M; Fox J; Nasr M; Dal Pan GJ; Shriver Z; Langer RS; Venkataraman G; Austen KF; Woodcock J; Sasisekharan R
    N Engl J Med; 2008 Jun; 358(23):2457-67. PubMed ID: 18434646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin comes clean.
    Schwartz LB
    N Engl J Med; 2008 Jun; 358(23):2505-9. PubMed ID: 18525048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.